The Validity and Reliability Study of Turkish Version of the Sentiments Attitudes and Concerns about Inclusive Education Scale
Kastamonu Eğitim Dergisi · 15.03.2018 · 26 (2) · 271-280
DOI: 10.24106/kefdergi.389872 ↗Kurz gefasst
Fachartikel in der Zeitschrift Kastamonu Eğitim Dergisi, online erschienen am 15.03.2018. Verfasst von Nurcan Cansız und 1 weiteren Autor:innen. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 51 Literaturangaben.
Abstract (Originalsprache)
The purpose of this study is to translate and adapt the Sentiments Attitudes and Concerns about Inclusive Education Scale (SACIE) for use in the Turkish context. For this purpose, translated version of SACIE was administered to 304 and 368 preservice teachers (PTs) for performing exploratory and confirmatory factor analysis respectively. The result of exploratory factor analysis revealed the three-factor structure of SACIE as sentiments, attitudes, and concerns. The confirmatory factor analysis supported three-factor structure of SACIE including 19 items. Moreover, the scale indicated a reasonable predictive validity to the self-efficacies of preservice teachers. The importance of the adaptation of the scale into Turkish was discussed.
Zitieren
APA
Cansız, N., & Cansız, M. (2018). The Validity and Reliability Study of Turkish Version of the Sentiments Attitudes and Concerns about Inclusive Education Scale. Kastamonu Eğitim Dergisi, 26(2), 271-280. https://doi.org/10.24106/kefdergi.389872
Vancouver
Cansız N, Cansız M. The Validity and Reliability Study of Turkish Version of the Sentiments Attitudes and Concerns about Inclusive Education Scale. Kastamonu Eğitim Dergisi. 2018;26(2):271-280. doi:10.24106/kefdergi.389872
BibTeX
@article{Cansz2018,
author = {Cansız, Nurcan and Cansız, Mustafa},
title = {The Validity and Reliability Study of Turkish Version of the Sentiments Attitudes and Concerns about Inclusive Education Scale},
journal = {Kastamonu Eğitim Dergisi},
year = {2018},
volume = {26},
number = {2},
pages = {271--280},
doi = {10.24106/kefdergi.389872}
}
EUVIMED